Meticulous Research®, a prominent leader in market research, has announced the publication of a groundbreaking report titled “Cell Culture Market by Product (Consumables, Equipment), Application (Bioproduction, Cancer Research, Stem Cell, Diagnostics), End User (Pharmaceutical, Academic) – Global Forecast to 2029.” This detailed analysis predicts that the cell culture market will witness a robust compound annual growth rate (CAGR) of 11.7% during the forecast period from 2022 to 2029, ultimately reaching an impressive valuation of $48.63 billion.
Download Free Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=4788?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=23-10-2024
The surge in the biopharmaceutical sector, coupled with the increasing prevalence of chronic diseases and a growing demand for monoclonal antibodies, are the primary drivers propelling this market's growth. Furthermore, enhanced research funding and the rising adoption of single-use technologies are expected to significantly contribute to the market's expansion.
The report also highlights a notable trend: the increasing adoption of 3D cell culture and personalized medicine is anticipated to create substantial opportunities for stakeholders in the cell culture domain.
Impact of COVID-19 on Cell Culture Research
The COVID-19 pandemic has significantly influenced cell culture research activities. Understanding the kinetics of infectious viruses and developing effective control strategies became paramount during the initial outbreak. Researchers worldwide focused on studying various viral variants to establish new therapeutic approaches, initiating laboratory experiments to evaluate drug efficacy and vaccine effectiveness.
In vitro cell culture models played a pivotal role in these COVID-19 research projects. Human lung epithelium models, along with other cell types such as normal human bronchial epithelial cells and primary endothelial cells, were essential in addressing key areas of research, including antiviral studies, vaccine development, and virus stability investigations. Consequently, the pandemic positively impacted the demand for cell culture products.
Market Segmentation and Key Insights
The report provides an in-depth segmentation of the cell culture market based on product type, application, end user, and geography:
• Product Segmentation: The market is categorized into consumables (including media, reagents, sera, and cell lines) and equipment (such as bioreactors, incubators, and centrifuges). In 2022, the consumables segment dominated the market, driven by the increasing need for cell culture techniques across various applications.
• Application Segmentation: The market is segmented into bioproduction (including monoclonal antibody production, vaccine production, and gene therapy), drug screening and development, cancer research, stem cell research, and other applications. The bioproduction segment is anticipated to hold the largest market share due to the rising demand for biopharmaceuticals.
• End User Segmentation: The report identifies pharmaceutical and biotechnology companies as the leading end user segment, driven by the presence of major biotech firms and the growing number of startups investing in research and production capabilities.
• Geographical Analysis: The study evaluates key regions, including North America (U.S. and Canada), Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is projected to dominate the market in 2022, supported by a well-established healthcare system, advanced technology adoption, and ongoing expansion by biopharmaceutical manufacturers.
Leading Players in the Cell Culture Market
The report identifies major players operating in the cell culture market, including:
• Merck KGaA (Germany)
• Thermo Fisher Scientific Inc. (U.S.)
• Cytiva (U.S.)
• Lonza Group Ltd. (Switzerland)
• Corning Incorporated (U.S.)
• Becton, Dickinson and Company (U.S.)
• Avantor, Inc. (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• HiMedia Laboratories (India)
• Sartorius AG (Germany)
• Eppendorf SE (Germany)
• FUJIFILM Holdings Corporation (Japan)
• Agilent Technologies, Inc. (U.S.)
• Getinge AB (Sweden)
• Greiner Bio-One GmbH (Austria)
• Miltenyi Biotec B.V. & Co. KG (Germany)
Meticulous Research®’s report serves as a comprehensive resource for stakeholders aiming to navigate the evolving landscape of the cell culture market and capitalize on emerging opportunities.
Quick Buy @ https://www.meticulousresearch.com/Checkout/94004198?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=23-10-2024
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research